期刊文献+

布鲁氏菌强毒株与弱毒株基因组DNA差异基因筛选与鉴定 被引量:2

Screening and identification of the differential genomic DNA between Brucella abortus virulent strain and attenuated strain
下载PDF
导出
摘要 本研究应用代表性差异分析技术(RDA)对流产布鲁氏菌强毒株544A和弱毒株104M进行基因组差减分析。经过3轮差减杂交,获得强毒株特有的9条差异片段和弱毒株特异的17条差异片段。经BLAST分析和PCR鉴定,最终证实3条差异片段,与流产布鲁氏菌经典弱毒株S19同源性在98%~99%之间,只在弱毒株104M基因组中检测出,而在强毒株544A中不存在。该实验为建立布鲁氏菌自然感染菌与疫苗株的基因鉴别诊断方法奠定了基础。 The differential genomic DNA between Brucella abortus virulent strain 544 A and Brucella abortus attenuated strain 104 M was screened using representational difference analysis (RDA). Nine differential fragments in virulent strain 544 A and 17 differential fragments in attenuated strain 104 M were identified after three rounds of subtractive hybridization. Three differential fragments detected only in the attenuated strain 104 M, but not in virulent strain 544 A shared 98 % to 99 % homology with the classic Brucella abortus attenuated strain S19 in BLAST. It is possible to use these 3 differential fragments to establish a differential diagnosis for discriminating the Brucella infection from vaccination.
出处 《中国预防兽医学报》 CAS CSCD 北大核心 2009年第7期513-518,共6页 Chinese Journal of Preventive Veterinary Medicine
基金 吉林省省长基金(20070613)
关键词 流产布鲁氏菌 代表性差异分析 差异片段 鉴定 Brucella abortus representational difference analysis (RDA) difference fragments identification
  • 相关文献

参考文献1

  • 1[美]萨姆布鲁克(Sambrook,J·)等 著,金冬雁等.分子克隆实验指南[M]科学出版社,1992.

同被引文献128

  • 1高淑芬,冯静兰.中国布鲁氏菌病及其防治(1982-1991)[M].北京:中国科技出版社,1991.
  • 2孙承恩.布鲁氏菌104M活菌苗不同免疫途径的探讨[J].宁夏医学杂志,1985,(1):20-21.
  • 3Moreno E. Retrospective and prospective perspectives on zoonot- ic brucellosis[J]. Front Microbiol, 2014, 5(213): 1-18. DOI: 10. 3389/fmicb. 2014. 00213.
  • 4Galinska EM, Zagorski J. Brucellosis in humans-etiology, diag- nostics, clinical forms[J]. Ann Agric Environ Med, 2013, 20 (2) : 233-238.
  • 5Perkins SD, Smither SJ, Atkins HS. Towards a Brucella vac- cine for humans[J]. FEMS Microbiol Rev, 2010, 34(3): 379-394.
  • 6Vershilova P. The use of live vaccine for vaccination of human beings against brucellosis in the USSR[J]. Bull WHO, 1961, 24 (1): 85-89.
  • 7Deqiu S, Donglou X, Jiming Y. Epidemiology and control of bru- cellosis in China[J]. Vet Microbiol, 2002, 90 (1): 165-182. DO1: 10. 1016/S0378-1135(02)00252-3.
  • 8Spink WW, Hall JW, Finstad J, et al. Immunization with viable Brucella organisms. Results of a safety test in humans[J]. Bull World Health Organ, 1962, 26(1) : 409-419.
  • 9Elberg SS, Faunce W Jr. Immunization against Brucella infec tion: 10. The relative immunogenicity of Brucella abortus strain 19 BA and Brucella melitensis strain Rev I in Cynomolgus philip- pinensis[J]. Bull WHO, 1964, 30(5): 693.
  • 10Hadjichristodoulou C, Voulgaris P, Toulieres L, et al. Toler ance of the human brucellosis vaccine and the intradermal reac- tion test for brucellosis[J]. Eur J Clin Microbiol Infect Dis, 1994, 13(2): 129 134. DOI: 10,1007/BF01982185.

引证文献2

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部